Clinical Trial Update: Immunotherapy With or Without Radiation Therapy for Metastatic Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of immunotherapy with or without radiation therapy for metastatic urothelial carcinoma, including platinum-resistant disease and stage IV bladde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Platinum-resistant Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Immunotherapy (immunotherapy)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Urothelial Carcinoma, Platinum-Resistant Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2025-08-17